Litigation Details for Takeda Pharmaceuticals U.S.A., Inc. v. Macleods Pharmaceuticals Ltd. (D. Del. 2017)
✉ Email this page to a colleague
Takeda Pharmaceuticals U.S.A., Inc. v. Macleods Pharmaceuticals Ltd. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-10-17 |
Court | District Court, D. Delaware | Date Terminated | 2018-02-02 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,296; 8,093,297; 8,093,298; 8,097,655; 8,415,395; 8,415,396; 8,440,721; 8,440,722 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Takeda Pharmaceuticals U.S.A., Inc. v. Macleods Pharmaceuticals Ltd.
Details for Takeda Pharmaceuticals U.S.A., Inc. v. Macleods Pharmaceuticals Ltd. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-10-17 | 1 | G. United States Patent Number 7,601,758 (“the ’758 Patent”), entitled “METHODS FOR CONCOMITANT…States Patent Nos. 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; 7,619,004; 7,601,758; 7,820,681…722 Patents are collectively referred to herein as the “Gout Patents.” (The ’648 and ’297 patents are…are both FMF Patents and Gout Patents.) 34. All of the above-listed patents are collectively…648 Patent, including at least claim 1 of the ’648 patent, and that the claims of the ’648 Patent are | External link to document | |
2018-02-01 | 13 | 8,093,298; 7,964,648; 8,093,297; US 7,619,004; US 7,601,758; US 7,820,681; US 7,915,269; US 7,964,647; US … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731…2017 2 February 2018 1:17-cv-01469 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |